Several multiple sclerosis drugs covered by Pharmacare in every province except B.C.
When Deborah Stefanek was 38 years old, the mother of four from Kimberley, B.C. was diagnosed with relapsing remitting multiple sclerosis.
That was in 2018, and she hoped a healthy lifestyle would enable her to stay off medication. She changed her diet and started an exercise routine. But after an MRI last fall showed her disease is progressing, Stefanek’s neurologist recommended she begin taking a new medication called Kisempta.
The drug’s manufacturer agreed to temporarily provide the medication free of charge while Stefanek looked into coverage through Pharmacare and private insurance.
“And it came back that my husband’s insurance would only cover 45 per cent of the cost of Kesimpta, which would mean we would have to pay $19,000 out of pocket, because B.C. Pharmacare doesn’t cover it,” said Stefanek.
She was shocked to learn every province in Canada covers Kisempta under their Pharmacare plans except B.C. It’s the same situation for a similar drug called Ocrevus. Stefanek’s friend Andrea Rollheiser, who also has RRMS, was told by her neurologist that Ocrevus is the best drug for her, but it too isn’t covered by B.C. Pharmacare.
The province’s health critic Shirley Bond says that’s unacceptable.
“As patients in British Columbians look across the country, British Columbia is an island on this issue unto itself. And it very hard for people to understand why other jurisdictions, including the one next door to us, can figure out how to cover these drugs,” said Bond, who believes it’s all about cost.
Roche Canada, the maker of Ocrevus, is hoping the B.C. government will reverse course and cover both drugs, which are approved by Health Canada and have been proven to reduce the number and severity of MS relapses.
“All of the other provincial governments have made the decision to make this medicine available, they felt it was a valuable medicine for those living with MS in thier province. And we are equally hopeful that we can have a discussion with the government of British Columbia so that a similar decision can be made,” said Roche Canada president and CEO Brigitte Nolet.
Bond says the opposition will continue to push the government to reconsider its decision on Kesimpta and Ocrevus. And she hopes patients keep speaking out.
“I think it is important for people to speak up and remind the government, and certainly we are doing that as well, that other jurisdictions have figured this out, have approved it. And MS patients, particularly those that suffer from relapse, are being treated differently in B.C. than the rest of the country,” said Bond.
Stefanek says with the bridge financing from the drug company now over, she can only remain on Kestimpa if it’s covered by Pharmacare.
“As it stands right now, we cannot afford that $19,000. So currently, I’m not on the medication,” she said.
And that has her worried she’s at risk for relapse, which could leave her bedridden and unable to care for her kids.
“I need to keep moving, being able to support them and provide for them,” Stefanek said. “If I’m sick, I’m no good to anybody.”
CTVNews.ca Top Stories
Why drivers in Ontario, Quebec and Atlantic Canada will see a gas price spike, and other Canadians won't
Drivers in Eastern Canada face a big increase in gas prices because of various factors, especially the higher cost of the summer blend, industry analysts say.
'A living nightmare': Winnipeg woman sentenced following campaign of harassment against man after online date
A Winnipeg woman was sentenced to house arrest after a single date with a man she met online culminated in her harassing him for years, and spurred false allegations which resulted in the innocent man being arrested three times.
How to avoid the trap of becoming 'house poor'
The journey to home ownership can be exciting, but personal finance columnist Christopher Liew warns about the trappings of becoming 'house poor' -- where an overwhelming portion of your income is devoured by housing costs. Liew offers some practical strategies to maintain better financial health while owning a home.
It's the biggest election in history. Here's why few Indians in Canada will take part
In the Indian general election that gets underway on Friday, almost a billion people are eligible to vote, but a vast majority of the overseas Indian community in Canada won't be casting a ballot.
McDonald's customers left with 'zero value' collection of free hot drink stickers after company ends program
It took years for Vinnie Deluca to collect more than 400 cards worth of free McDonald's McCafe coffee, a collection that now has "zero value" after the company discontinued the program.
Jury selection in Trump hush money trial faces pivotal stretch as former U.S. president returns to court
Jury selection in the hush money trial of Donald Trump enters a pivotal and potentially final stretch Thursday as lawyers look to round out the panel of New Yorkers that will decide the first-ever criminal case against a former president.
Toxic forever chemicals in drinking water: Is Canada doing enough?
As the United States sets its first national limits on toxic forever chemicals in drinking water, researchers say Canada is lagging when it comes to regulations.
Where did the gold go? Crime expert weighs in on unfolding Pearson airport heist investigation
Almost 7,000 bars of pure gold were stolen from Pearson International Airport exactly one year ago during an elaborate heist, but so far only a tiny fraction of that stolen loot has been found.
Biden scores endorsements from Kennedy family, looking to shore up support against Trump and RFK Jr.
U.S. President Joe Biden will accept endorsements from at least 15 members of the Kennedy political family during a campaign stop in Philadelphia on Thursday as he aims to undermine Donald Trump and marginalize the candidacy of Robert F. Kennedy Jr.